ArticleWorld journal of clinical cases2021

Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension.

Ci Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.